| Data | Descrição | Vacina | Quantidade 1° dose | Quantidade 2° dose | Quantidade 1° dose extra | Quantidade 2° dose extra | Quantidade de doses indigena | Total |
| 25/11/2021 | VACINA CONTRA SAR-COV2 - 05 DOSES | BNT162b2 - BioNTech/Fosun Pharma/Pfizer | 42 | 0 | 0 | 0 | 0 | 660 |
| 02/12/2021 | VACINA CONTRA SARS-COV2 - 06 DOSES | BNT162b2 - BioNTech/Fosun Pharma/Pfizer | 300 | 108 | 0 | 0 | 0 | 1.374 |
| 02/12/2021 | VACINA CONTRA SARS-COV2 - 10 DOSES | Butantan/CoronaVac | 140 | 0 | 0 | 0 | 0 | 140 |
| 14/12/2021 | VACINA CONTRA SARS-COV2 05 DOSES | Janssen Covid-19 Vaccine | 0 | 0 | 0 | 0 | 0 | 40 |
| 14/12/2021 | VACINA CONTRA SARS-COV2 06 DOSES | BNT162b2 - BioNTech/Fosun Pharma/Pfizer | 6 | 54 | 0 | 0 | 0 | 907 |
| 20/12/2021 | VACINA CONTRA SARS-COV2 - 05 DOSES | Janssen Covid-19 Vaccine | 0 | 0 | 0 | 0 | 0 | 165 |
| 20/12/2021 | VACINA CONTRA SARS-COV2 - 06 DOSES | BNT162b2 - BioNTech/Fosun Pharma/Pfizer | 0 | 0 | 0 | 0 | 0 | 186 |
| 03/01/2022 | VACINA CONTRA SARS-COV2 05 DOSES | Fiocruz/Oxford/AstraZeneca | 10 | 10 | 0 | 0 | 0 | 180 |
| 07/01/2022 | VACINA CONTRA SARS-COV2 - 06 DOSES | BNT162b2 - BioNTech/Fosun Pharma/Pfizer | 0 | 0 | 0 | 0 | 0 | 1.026 |
| 14/01/2022 | VACINA CONTRA SARS-COV2 - PEDIATRICA - 10 DOSES | BNT162b2 - BioNTech/Fosun Pharma/Pfizer | 130 | 0 | 0 | 0 | 0 | 130 |
| 17/01/2022 | VACINA CONTRA SARS-COV2 - 06 DOSES | BNT162b2 - BioNTech/Fosun Pharma/Pfizer | 0 | 0 | 0 | 0 | 0 | 714 |
| 17/01/2022 | VACINA CONTRA SARS-COV2 - 05 DOSES | Janssen Covid-19 Vaccine | 0 | 0 | 0 | 0 | 0 | 90 |
| 21/01/2022 | VACINA CONTRA SARS-COV2 - 06 DOSES | BNT162b2 - BioNTech/Fosun Pharma/Pfizer | 0 | 0 | 0 | 0 | 0 | 1.260 |
| 21/01/2022 | VACINA CONTRA SARS-COV2 - 05 DOSES | Fiocruz/Oxford/AstraZeneca | 0 | 0 | 0 | 0 | 0 | 15 |
| 21/01/2022 | VACINA CONTRA SARS-COV2 - 10 DOSES | Butantan/CoronaVac | 0 | 0 | 0 | 0 | 0 | 20 |
| 21/01/2022 | VACINA CONTRA SARS-COV2 - PEDIATRICA - 10 DOSES | BNT162b2 - BioNTech/Fosun Pharma/Pfizer | 140 | 0 | 0 | 0 | 0 | 140 |
| 31/01/2022 | VACINA CONTRA SARS-COV2 - 06 DOSES | BNT162b2 - BioNTech/Fosun Pharma/Pfizer | 0 | 0 | 0 | 0 | 0 | 180 |
| 31/01/2022 | VACINA CONTRA SARS-COV2 - 06 DOSES | BNT162b2 - BioNTech/Fosun Pharma/Pfizer | 0 | 0 | 0 | 0 | 0 | 180 |
| 03/02/2022 | VACINA CONTRA SARS-COV2 - 01 DOSES | Butantan/CoronaVac | 330 | 330 | 0 | 0 | 0 | 660 |
| 03/02/2022 | VACINA CONTRA SARS-COV2 - 05 DOSES | Fiocruz/Oxford/AstraZeneca | 0 | 0 | 0 | 0 | 0 | 235 |
| 07/02/2022 | VACINA CONTRA SARS-COV2 - 01 DOSE | Butantan/CoronaVac | 0 | 100 | 0 | 0 | 0 | 660 |
| 07/02/2022 | VACINA CONTRA SARS-COV2 - 05 DOSES | Fiocruz/Oxford/AstraZeneca | 235 | 0 | 0 | 0 | 0 | 235 |
| 07/02/2022 | VACINA CONTRA SARS-COV2 - PEDIATRICA - 10 DOSES | PFIZER PEDIÁTRICA | 160 | 0 | 0 | 0 | 0 | 160 |
| 07/02/2022 | VACINA CONTRA SARS-COV2 05 DOSES | Fiocruz/Oxford/AstraZeneca | 0 | 0 | 0 | 0 | 0 | 235 |
| 15/02/2022 | VACINA CONTRA SARS-COV2 - 05 DOSES | Janssen Covid-19 Vaccine | 0 | 0 | 0 | 0 | 0 | 60 |
| 15/02/2022 | VACINA CONTRA SARS-COV2 - 06 DOSES | BNT162b2 - BioNTech/Fosun Pharma/Pfizer | 0 | 0 | 0 | 0 | 0 | 292 |
| 17/02/2022 | VACINA CONTRA SARS-COV2 05 DOSE | Fiocruz/Oxford/AstraZeneca | 20 | 0 | 0 | 0 | 0 | 20 |
| 21/02/2022 | VACINA CONTRA SARS-COV2 - 06 DOSES | BNT162b2 - BioNTech/Fosun Pharma/Pfizer | 0 | 0 | 0 | 0 | 0 | 25 |
| 21/02/2022 | VACINA CONTRA SARS-COV2 - PEDIATRICA - 10 DOSES | BNT162b2 - BioNTech/Fosun Pharma/Pfizer | 160 | 0 | 0 | 0 | 0 | 160 |
| 21/02/2022 | VACINA CONTRA SARS-COV2 - 05 DOSES | Butantan/CoronaVac | 0 | 0 | 0 | 0 | 0 | 465 |
